EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

UNICORN During Transcatheter Aortic Valve Replacement in Native and Bioprosthetic Aortic Valves

Elsa Hebbo, John T D'Angelo, Anton Camaj, Anas T Noman, Hiroki A Ueyama, Liana T Alcaro, Roger J Laham, Gennaro Giustino, Mostafa Naguib, Adnan M Halboni, Pedro A Villablanca, David J Hildick-Smith und 12 weitere

JACC: Cardiovascular Interventions · 2026

DOI: 10.1016/j.jcin.2026.04.030 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2026. Verfasst von Elsa Hebbo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Emory University Hospital Midtown, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Aortic Valve, Transcatheter Aortic Valve Replacement, Bioprosthesis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: UNICORN (undermining coronary obstruction with radiofrequency "needle") has been adopted by some operators to prevent coronary obstruction during transcatheter aortic valve replacement (TAVR). More clinical data are needed to evaluate UNICORN outcomes. OBJECTIVES: The aim of this study is to describe preliminary outcomes of UNICORN during TAVR. METHODS: Nine sites contributed consecutive patients undergoing UNICORN TAVR from March 2024 to May 2025. Primary success was UNICORN TAVR without composite periprocedural coronary obstruction, reintervention, or death. Primary safety endpoints were intraprocedural hypotension plus overall 30-day safety, which included 30-day death, stroke, coronary obstruction requiring reintervention, stage 3 or 4 acute kidney injury, life-threatening bleeding, major vascular complication, and valve-related reintervention. Two UNICORN techniques, intraleaflet deployment and full-leaflet tearing, were used. RESULTS: Fifty-three patients (8 native aortic valves, 30 surgical valves, and 15 transcatheter valves) were included. Left-sided and right-sided UNICORN procedures were performed in 30 (57%) and 19 (36%), respectively. UNICORN was bilateral in 4 (8%). Eleven (21%) underwent contralateral BASILICA (bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction), and 3 (6%) received contralateral snorkel-stent protection. Forty patients (76%) underwent intraleaflet deployment, and 13 (24%) underwent full-leaflet tearing. Primary success occurred in 51 patients (96%). Two (4%) experienced coronary obstruction and required rescue percutaneous coronary intervention. Overall 30-day safety was observed in 46 patients (87%), with strokes in 3 (6%), life-threatening bleeding in 2 (4%), and major vascular complications in 2 (4%). Intraprocedural hypotension occurred in 12 (23%). There were no deaths, valve-related reinterventions, or stage 3 to 4 acute kidney injury at 30 days. CONCLUSIONS: UNICORN during TAVR was successful in preventing coronary obstruction. Intraprocedural hypotension requiring vasopressor support was frequent. UNICORN should be considered in cases in which lower risk options are unlikely to be successful.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisAortic ValveTranscatheter Aortic Valve ReplacementBioprosthesisAortic Valve StenosisCoronary StenosisHumansTreatment OutcomeFemaleAged, 80 and overMaleTime FactorsRisk FactorsProsthesis DesignAgedRisk Assessment

Stichwörter der Autor:innen

BASILICAcoronary occlusion/prevention and control/etiology/diagnostic imaging/physiopat…iatrogenic disease/prevention and controltranscatheter aortic valve replacement/adverse effects/instrumentation

Autor:innen und Institutionen

  • Emory University Hospital Midtown, Atlanta, Georgia, USA.
  • Mount Sinai Fuster Heart Hospital, New York, New York, USA.
  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Atlantic Health System, Morristown, New Jersey, USA.
  • Henry Ford Hospital, Detroit, Michigan, USA.
  • University Hospitals Sussex NHS Foundation Trust, Brighton and Hove, United Kingdom.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Hebbo, E., D'Angelo, J. T., Camaj, A., Noman, A. T., Ueyama, H. A., Alcaro, L. T., Laham, R. J., Giustino, G., Naguib, M., Halboni, A. M., Villablanca, P. A., Hildick-Smith, D. J., Saxon, J. T., Khan, J. M., Rogers, T., Pop, A. M., Ahmad, Y., Gleason, P. T., Lisko, J. C., …, & Byku, I. (2026). UNICORN During Transcatheter Aortic Valve Replacement in Native and Bioprosthetic Aortic Valves. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2026.04.030

Vancouver

Hebbo E, D'Angelo JT, Camaj A, Noman AT, Ueyama HA, Alcaro LT, et al. UNICORN During Transcatheter Aortic Valve Replacement in Native and Bioprosthetic Aortic Valves. JACC: Cardiovascular Interventions. 2026. doi:10.1016/j.jcin.2026.04.030

BibTeX
@article{Hebbo2026,
  author = {Hebbo, Elsa and D'Angelo, John T and Camaj, Anton and Noman, Anas T and Ueyama, Hiroki A and Alcaro, Liana T and Laham, Roger J and Giustino, Gennaro and Naguib, Mostafa and Halboni, Adnan M and Villablanca, Pedro A and Hildick-Smith, David J and Saxon, John T and Khan, Jaffar M and Rogers, Toby and Pop, Andrei M and Ahmad, Yousif and Gleason, Patrick T and Lisko, John C and Shekiladze, Nikoloz and Lederman, Robert J and Greenbaum, Adam B and Babaliaros, Vasilis C and Byku, Isida},
  title = {UNICORN During Transcatheter Aortic Valve Replacement in Native and Bioprosthetic Aortic Valves},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  doi = {10.1016/j.jcin.2026.04.030}
}
Kostenlos starten →